What it sells
Artificial intelligence for drug discovery.
Business model breakdown
Workflow: what inputs become what output?
UnverifiedAI platform to explore chemical space and identify novel small-molecule drug candidates, plus internal therapeutic programs in immune and inflammatory diseases.
Economics: what it saves and how it charges
UnverifiedPlatform plus proprietary drug programs; likely partnering/licensing with pharma (not stated).
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2015 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.